P.133 Paediatric dosing of balovaptan for the treatment of the core symptoms of autism spectrum disorder: data from a Phase 2 study (aV1ation; NCT02901431)

Saved in:
Bibliographic Details
Published in:European neuropsychopharmacology 2020-11, Vol.40, p.S82-S83
Main Authors: Stark, F. Schaedeli, Chavanne, C., Lennon-Chrimes, S., Diack, C., Derks, M., Smith, J.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0924-977X
1873-7862
DOI:10.1016/j.euroneuro.2020.09.110